Two Sigma Securities’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Two Sigma Securities’s Portfolio CORV Stock Details CORV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10,437	Closed	-$4K	–	1873
2020 Q1	$4K	Buy	+10,437	New	+$3.78K	﹤0.01%	1269

Two Sigma Securities's CORV Position: Q2 2020 in Review

Two Sigma Securities sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2020, closing a stake of 10,437 shares — an estimated $4K sold.

Two Sigma Securities first reported a position in CORV in Q1 2020 and held it in 1 quarter. The position peaked at $4K in Q1 2020. 0 funds tracked by Wall St. Rank hold CORV as of Q2 2020.

Two Sigma Securities reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2020 after selling out during the quarter.
Two Sigma Securities sold 10,437 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2020, an estimated $4K.
Two Sigma Securities first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q1 2020 and held it in 1 quarter.
Two Sigma Securities's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $4K in Q1 2020.
0 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2020.

Based on Two Sigma Securities's 13F filing for Q2 2020, filed 14 Aug 2020.